𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of orchiectomy on structures of the thymus expressing major histocompatibility complex class II molecules

✍ Scribed by I. L. Sarilova; V. E. Sergeeva; A. T. Smorodchenko

Publisher
Springer US
Year
2008
Tongue
English
Weight
428 KB
Volume
145
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of class I and class II major
Expression of class I and class II major histocompatibility complex antigens on human hepatocytes
✍ Alessandra Franco; Vincenzo Barnaba; Piergiorgio Natali; Clara Balsano; Antonino πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 715 KB

We analyzed whether normal human hepatocytes, which normally do not display Class I1 major histocompatibility complex antigens, can be induced to express them in vitro, and whether this induction has an in vivo counterpart in chronic liver diseases. While both a-and y-interferon induced expression o

Hepatic expression of class I and class
Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid
✍ Yvon Calmus; Pierre Gane; Philippe Rouger; Raoul Poupon πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 410 KB

Aberrant hepatic expression of HLA molecules has been shown to be present in primary biliary cirrhosis and may play a determining role in the pathogenesis of the disease. We have studied the effect of the long-term administration of ursodeoxycholic acid on hepatic HLA expression. Nine untreated pati

The effect of photodynamic therapy on tu
The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules
✍ Alan Belicha-Villanueva; Jonah Riddell; Naveen Bangia; Sandra O. Gollnick πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 299 KB

## Abstract ## Background and Objective Photodynamic therapy (PDT) is FDA‐approved anti‐cancer modality for elimination of early disease and palliation in advanced disease. PDT efficacy depends in part on elicitation of a tumor‐specific immune response that is dependent on cytotoxic T lymphocytes